Pascale Bouchard, Author at Triple Hair

TH07 Clinical Study Featured in Peer-Reviewed Scientific JournalPosted on April 8, 2025 (April 8, 2025) by Pascale BouchardinScience
Triple Hair Group Enters Into Licensing Agreement with Akums for Therapy-07 in IndiaPosted on October 23, 2024 by Pascale BouchardinCorporate
Triple Hair Group Receives EMA Approval to Start Phase III Clinical Trials on its Therapy-07 Prescription Drug in EuropePosted on June 19, 2024 (June 19, 2024) by Pascale BouchardinCorporate
Triple Hair’s Feature in Le Journal de MontréalPosted on June 11, 2024 (June 11, 2024) by Pascale BouchardinIn the medias
Triple Hair Group Closes $4 Million FinancingPosted on June 3, 2024 by Pascale BouchardinCorporate&In the medias
Triple Hair Wins “Jury’s Choice Award” at Octane Aesthetic Tech ForumPosted on February 12, 2024 (February 12, 2024) by Pascale BouchardinCorporate&In the medias
Triple Hair Group Signs Licensing Agreement for South Korean Market with Mother’s PharmaceuticalPosted on October 17, 2023 (February 15, 2024) by Pascale BouchardinCorporate&In the medias
OpportunitiesNB Article on an interview with our CEO Jean-Phillipe GravelPosted on July 27, 2023 by Pascale BouchardinCorporate&In the medias
Triple Hair Group receives Health Canada approval to start Phase III clinical trials on its Therapy-07 prescription drug in CanadaPosted on June 28, 2023 by Pascale BouchardinCorporate&Science
Can anxiety or even mental health affect hair loss?Posted on June 22, 2023 by Pascale BouchardinALOPECIA